Repare Therapeutics Inc (RPTX) - News Archive

Repare Therapeutics Inc. (NASDAQ: RPTX), a clinical-stage precision oncology company, has announced it will present initial topline data from the Phase 1 LIONS (NCT06232408) clinical trial at the forthcoming 37th AACR-N...

The Path to Innovation: DCx Biotherapeutics Strategic Leap Forward In a bold maneuver that underscores its commitment to innovative therapies in biomedicine, DCx Biotherapeutics Corporation (DCx) has strategically align...

: Repare Therapeutics Inc. a notable player in the field of precision oncology, has announced the acceptance of six abstracts for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeti...

The rapidly evolving field of precision oncology is set to witness another significant leap forward as Repare Therapeutics Inc. (Nasdaq: RPTX) prepares to unveil a suite of new research findings at the American Associat...

CAMBRIDGE, Mass. & MONTREAL Repare Therapeutics Inc. (Nasdaq: RPTX), a prominent player in precision oncology, has provided an extensive update on its business operations and clinical progress alongside its financial re...

CAMBRIDGE, Mass. & MONTREAL Repare Therapeutics Inc. (Nasdaq: RPTX), a leading clinical-stage precision oncology company, continues to make significant strides in the realm of targeted cancer therapies. The company rece...

Repare Therapeutics Announces Milestone CAMBRIDGE, Mass. & MONTREAL - Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a pioneering clinical-stage precision oncology company, has reached a significant mi...

By Author Name CAMBRIDGE, Mass. & MONTREAL October 12, 2023 Repare Therapeutics Inc., a front-runner in the field of precision oncology, has achieved significant milestones that promise to revolutionize the treatment la...

Repare Therapeutics Making Strides in Precision Oncology: A Look at Their First Quarter 2024 Progress and Financial ResultsCambridge, Mass. & Montreal - Repare Therapeutics Inc. (Nasdaq: RPTX), a renowned clinical-stage...

Repare Therapeutics Inc., a leader in clinical-stage precision oncology, in collaboration with Debiopharm, a privately-owned Swiss biopharmaceutical company, have made ground-breaking strides in cancer treatment. Both c...